I was interested in finding another cost advantage in using EdenCrete. More specifically a cost advantage to contractors when including EdenCrete in their concrete mix design when tendering for projects.
There is some info from FHWA (from part 1 at link below) that says,
The short and long-term cost effectiveness of warranties is an issue that all agencies have to address. Evaluations from short and long-term HMA warranties reported by agencies across the country have shown an increase in the initial construction costs of the project by 3 percent to 15 percent.[5,6] The increased costs of the warranty are directly related to the increased risk perceived by the contractor.
More FHWA reading here, https://www.fhwa.dot.gov/pavement/warranty/guidance.cfm
Korea has also pursued development of a performance criteria for warranty specification. https://www.researchgate.net/public...ia_for_Korean_Pavement_Warranty_Specification
I think it would be fair to say that any 'perceived' increased cost attributed to EdenCrete could be well and truely absorbed by saving much of the 3-15% increase attributed to the warranty.
Another selling point?
- Forums
- ASX - By Stock
- EDE
- Pavement Warranty
Pavement Warranty
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EDE (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.162M |
Open | High | Low | Value | Volume |
0.1¢ | 0.2¢ | 0.1¢ | $755 | 505K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
54 | 122838472 | 0.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.2¢ | 1893120 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
54 | 122838472 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.002 | 1893120 | 8 |
0.003 | 32981361 | 23 |
0.004 | 5420102 | 4 |
0.005 | 1200000 | 3 |
0.006 | 245010 | 2 |
Last trade - 12.58pm 12/11/2024 (20 minute delay) ? |
Featured News
EDE (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online